Wanbury
WANBURY • Pharmaceuticals & Biotechnology
Last Price
₹192.36
Market Cap
₹672.62 Cr
Sector
Pharmaceuticals & Biotechnology
For educational/research use only. Not a recommendation to buy or sell.
At a glance
as of 2026-10-16Sector: Wanbury (WANBURY) is an NSE-listed company in the Pharmaceuticals & Biotechnology sector, within the Pharmaceuticals industry. NSE sector rotation chart
Sharia rating: Wanbury is rated Not halal by a specialist third-party provider. Full list of halal NSE stocks
44% below its 52-week high
Price trend
Strongly negative
Over the last 6 months, Wanbury's share price has fallen, doing better than 3% of Pharmaceuticals & Biotechnology stocks.
Institutional activity
Neutral
Trading patterns over recent weeks show no clear sign of institutions buying or selling Wanbury (buying score 2/10, selling score 2/10).
Model rank
Strongly positive
Our model's 5-day return score puts Wanbury ahead of 85% of NSE stocks. The model is only moderately confident (70%).
Ease of trading
Low
Shares change hands easily; there are no signs of trading drying up (risk score 1/10).
Price vs profits
Below typical
The share price is 10× last year's profit per share — below the typical range for NSE stocks (15–30×).
The wider Indian market is in a crisis regime — unusually sharp moves (model 99% sure). This affects every stock's model rank.
Browse ready-made screens →Company Information
About Wanbury (WANBURY)
Wanbury is an NSE-listed company operating in the Pharmaceuticals & Biotechnology sector, within the Pharmaceuticals industry (ISIN INE107F01022). This page brings together the quantitative research signals our models compute for WANBURY: a model-estimated 1-day, 5-day and 21-day return outlook, momentum and trend indicators, institutional-activity context derived from observed trading flows, a snapshot of valuation and quality fundamentals, and the instrument's Sharia-compliance status. All figures are produced by statistical models from historical data and are intended for research and educational purposes.
To read the page, treat the model-estimated return outlook as a relative ranking signal rather than a forecast of price — higher scores reflect stronger model-estimated momentum and trend alignment, not a target or guarantee. The momentum and trend indicators describe how Wanbury's recent price action compares with its own history, while the fundamentals and institutional-activity context add longer-horizon and flow-based perspective. Nothing here is investment advice, a recommendation, or a solicitation to transact; always do your own research and consult a SEBI-registered adviser before making any decision.
The "typical range" we compare a price-to-earnings multiple against is a fixed band for all NSE stocks, not a sector-specific one. Everything on this page describes what our models measured; none of it is a recommendation to do anything.